EXACTMEDS
Live / Registered — Registered (as of 04 Oct 2022)
What this means for you
Registered since 04 Oct 2022. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 04 Oct 2028: the §8 declaration of use).
Record
- Serial number
- 90694071
- Registration number
- 6862357
- Mark type
- Word mark
- Filed
- 06 May 2021
- Published for opposition
- 15 Feb 2022
- Registered
- 04 Oct 2022
- Next maintenance filing
- §8 declaration of use, due by 04 Oct 2028 (grace period to 04 Apr 2029)
- Attorney of record
- Robert W. Coykendall
Goods and services
- Class 044 — Medical, beauty and agricultural services: DNA screening for medical purposes, specifically for the purpose of individuals response to medications in order to select, calibrate individual medication dosages, and determine the sequence and timing of the dosages excluding diagnostic and screening tests and laboratory services for disease or predisease detection, monitoring or surveillance
Owner
- RxGenomix, LLC, Franklin, TN, US
- RxGenomix, LLC, Franklin, TN, US
- RxGenomix, LLC, Franklin, TN, US
Board proceedings on this mark
- Extension of Time to Oppose No. 90694071 — Exact Sciences Corporation v. RxGenomix, LLC, filed 07 Mar 2022 (Terminated)
Prosecution history
- 04 Oct 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Oct 2022 — REGISTERED-PRINCIPAL REGISTER
- 25 Aug 2022 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 02 Aug 2022 — POST PUBLICATION AMENDMENT - ENTERED
- 01 Aug 2022 — ASSIGNED TO PETITION STAFF
- 14 Jul 2022 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 07 Mar 2022 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 15 Feb 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Feb 2022 — PUBLISHED FOR OPPOSITION
- 26 Jan 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 12 Jan 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Jan 2022 — EXAMINER'S AMENDMENT ENTERED
- 12 Jan 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 12 Jan 2022 — EXAMINERS AMENDMENT E-MAILED
- 12 Jan 2022 — EXAMINERS AMENDMENT -WRITTEN